Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth (Status and Outlook) 2025-2031

Report ID: 3036094 | Published Date: Dec 2025 | No. of Page: 126 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025

The global Veterinary Active Pharmaceutical Ingredients Manufacturing market size is predicted to grow from US$ 7460 million in 2025 to US$ 11260 million in 2031; it is expected to grow at a CAGR of 7.1% from 2025 to 2031.

Veterinary active pharmaceutical ingredients manufacturing are made by more than one reaction from raw materials. It generally becomes an active pharmaceutical ingredients through the chemical compounds. The active pharmaceutical ingredients manufacturing utilize specific standards for determining how strong it is in every drug.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years.

  • According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021.
  • White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age.
  • From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%.
  • Almost 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 125%.

Segmentation by Type:

  • Antiparasitic
  • Anti-infectives
  • NSAIDs
  • Others

Segmentation by Application:

  • Companion Animals
  • Production/Food Animals

Market by Region:

  • Americas
  • APAC
  • Europe
  • Middle East & Africa

Company’s Coverage:

  • Alivira Animal Health Ltd.
  • Chempro Pharma Private Ltd.
  • Excel Industries Ltd.
  • FIS - Fabbrica Italiana Sintetici S.p.A.
  • HIKAL Ltd.
  • HuBei Masteam Bio-tech
  • Hunan Huateng Pharmaceutical
  • Jiangsu Rivocean
  • Ofichem Group
  • Qilu Pharma Spain, S.A.
  • Menadiona
  • Nissan Chemical
  • SUANFARMA
  • Siflon Drugs
  • Shaanxi Dideu Group
  • Taizhou Crene Biotechnology
  • Zhejiang Gihi Chemicals
  • Vetpharma (Insud Pharma, S.L.U)

Key Questions Addressed in this Report:
Frequently Asked Questions
Veterinary Active Pharmaceutical Ingredients Manufacturing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Veterinary Active Pharmaceutical Ingredients Manufacturing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Veterinary Active Pharmaceutical Ingredients Manufacturing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports